“I believe that pharmaceutical companies can do more than providing medicines” (Blog)
https://www.swisstph.ch/en/impact-stories/i-believe-that-pharmaceutical-companies-can-do-more-than-providing-medicines/blog-id/84
Lutz Hegemann, President of Global Health & Sustainability at Novartis, has been a member of the Board of Governors of Swiss TPH since 2023. In this interview, he tells us why he moved from being a do
Advanced Studies Programmes (MAS, DAS & CAS) - Swiss TPH (Page)
https://www.swisstph.ch/en/study-with-us/postgraduate/mas-das-cas
Advanced Studies Programmes – MAS, DAS and CAS At Swiss TPH, we offer exceptional master’s, diploma and certificate programmes (MAS, DAS and CAS) in global health and management, tailored to professio
Genotyping Group | Malaria Research at Swiss TPH (Page)
https://www.swisstph.ch/en/about/med/medicines-development/genotyping
Group | Genotyping Medicine Medicines Development Unit Diagnostic Development Genotyping Molecularimmunology Malaria molecular surveillance (MMS) is increasingly being implemented in malaria endemic c
Swiss TPH Communications (Page)
https://www.swisstph.ch/en/about/dir/communications
Communications at Swiss TPH The Communications unit coordinates media relations, organises symposia and events, publishes the annual report and other corporate material, and manages the Swiss TPH webs
Cancer Disparities | Research at Swiss TPH (Page)
https://www.swisstph.ch/en/about/eph/society-gender-and-health/cancer-disparities
Group | Cancer Disparities Epidemiology and Public Health Society, Gender and Health Cancer Disparities Gender and Inequities Cancer is the leading cause of morbidity and mortality: about 1 in 5 peopl
World Malaria Day 2024: Work together and accelerate the fight! (Page)
https://www.swisstph.ch/en/impact-stories/world-malaria-day-2024-work-together-and-accelerate-the-fight
Let me just share two examples, which show that progress is possible when people across cultures, sectors and systems work together to translate research into action and make a difference. The first e
Investigations of the metabolites of the trypanocidal drug melarsoprol (Publications)
BACKGROUND: Melarsoprol remains the first-choice drug for trypanosomiasis (human African sleeping sickness). To contribute to the sparse pharmacologic data and to better understand the cause of the fr
Noma: giving a face to a deadly disease (Page)
https://www.swisstph.ch/en/impact-stories/noma-giving-a-face-to-a-deadly-disease
Many people prefer to look the other way when it comes to this disease, as the sight of young children suffering from its effects is unbearable. It causes open wounds on the face and whole sections of
Water, Sanitation and Hygiene (Page)
https://www.swisstph.ch/en/topics/environment-and-health/water-sanitation-and-hygiene
Water, Sanitation and Hygiene Swiss TPH works on aspects of water, sanitation and hygiene (WASH) in countries where drinking water is scarce and where poor hygiene is a leading cause of infectious dis